For people living with depression, finding effective treatment can be a long and exhausting journey. Antidepressant medications may not provide sufficient relief, side effects can limit treatment options, and the process of trying different therapies can feel discouraging. Even when a patient finds a promising treatment, time commitment can become another barrier to care.
Transcranial magnetic stimulation (TMS) has become an important noninvasive treatment option for major depressive disorder, particularly for individuals who have not responded adequately to antidepressant medications. Traditionally, TMS is delivered five days a week over several weeks. But what if treatment could be completed in a much shorter period?
Accelerated TMS is changing the conversation around treatment convenience, access, and the possibility of earlier symptom improvement.
What Is TMS, and How Does Accelerated TMS Differ?
TMS uses magnetic pulses to stimulate specific brain regions involved in mood regulation, particularly areas of the prefrontal cortex. By influencing neural activity and brain networks associated with depression, TMS aims to help improve depressive symptoms. It does not require anesthesia and is generally performed in an outpatient setting.
Traditional TMS typically involves one session per day, five days a week, for approximately four to six weeks or longer, depending on the protocol and treatment plan. Some treatment courses extend beyond this period.
Accelerated TMS follows the same broad principle but delivers multiple treatment sessions per day, compressing the overall schedule into fewer days. Certain protocols use intermittent theta-burst stimulation (iTBS), a form of TMS that delivers patterned magnetic pulses in shorter sessions.
The term accelerated TMS describes a family of treatment approaches rather than one standardized procedure. Some protocols are completed over several days, while newer approaches may deliver a full course in a single day. The number of sessions, stimulation parameters, targeting methods, and follow-up plans vary.
Five Potential Benefits of Accelerated TMS
One of the most practical advantages is convenience. Traditional TMS often requires frequent clinic visits over several weeks. For patients balancing work, family responsibilities, childcare, school, or transportation challenges, this commitment can be difficult.
Accelerated protocols may substantially reduce the number of treatment days. For some patients, this can make TMS a more realistic option when a conventional schedule would be difficult to maintain.
Depression can affect sleep, concentration, motivation, relationships, and the ability to function at work or home. Understandably, patients want to know how soon they might feel better.
Some accelerated TMS studies have reported earlier improvement in depressive symptoms compared with once-daily treatment. A 2026 multisite randomized trial comparing accelerated and standard TMS using an H1 coil found that the accelerated group reached remission sooner, with comparable overall outcomes at six weeks.
However, faster treatment delivery does not guarantee faster recovery for every patient. Individual response varies, and improvement may continue to develop after the treatment course ends.
TMS is particularly relevant for patients with major depressive disorder who have not achieved adequate relief from medication. Accelerated approaches may expand the scheduling options available to eligible patients who are considering interventional psychiatry.
Research on highly accelerated protocols, including Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), has generated considerable interest because of promising results in treatment-resistant depression. These findings are encouraging, although outcomes from one specialized protocol should not be generalized to every accelerated TMS treatment.
Like traditional TMS, accelerated TMS does not require anesthesia and does not introduce a medication into the bloodstream. Patients generally remain awake during treatment and can usually return to their normal activities afterward, subject to their clinician’s guidance.
Common side effects include scalp discomfort and headache. Seizures are a rare but serious potential complication, and appropriate screening and monitoring remain essential. Accelerating the schedule does not eliminate the need for careful safety assessment.
For some patients, completing treatment over several days rather than several weeks may reduce disruptions to everyday life. Earlier assessment of response may also help clinicians and patients discuss the next steps in care.
Still, a shorter initial course does not mean that follow-up is unnecessary. Some patients may need ongoing medication management, psychotherapy, additional treatment, or maintenance sessions based on their clinical response.
Is Accelerated TMS Better Than Traditional TMS?
Not necessarily. The most appropriate treatment depends on the individual patient, the available protocol, clinical history, safety considerations, treatment goals, insurance coverage, and cost.
Traditional TMS remains an established option with a substantial evidence base. Accelerated TMS offers a potentially valuable alternative for patients who need a shorter treatment schedule or who may benefit from earlier symptom improvement.
The Future of Depression Treatment
The evolution of TMS reflects a broader goal in mental healthcare: making effective treatment more accessible, personalized, and compatible with patients’ lives.
For individuals who have spent months or years searching for relief, accelerated TMS may offer another option worth discussing with a qualified mental health professional. The most important measure of success is not simply how quickly treatment is delivered, but whether patients experience meaningful, lasting improvement in their symptoms and quality of life.
As interventional psychiatry continues to advance, the focus should remain on evidence-based care, realistic expectations, patient safety, and individualized treatment decisions.
